Literature DB >> 3897272

Comparison of measles antihemolysin test, enzyme-linked immunosorbent assay, and hemagglutination inhibition test with neutralization test for determination of immune status.

P W Neumann, J M Weber, A G Jessamine, M V O'Shaughnessy.   

Abstract

Sera were collected from 238 high-school students in Prince Edward Island for the determination of immune status before an anticipated measles outbreak. In addition, history of vaccination status and measles infection was obtained. In the subsequent outbreak, 28 students did contract measles. Specificity for hemagglutination inhibition (HI), antihemolysin (AH), and enzyme-linked immunosorbent assay (ELISA) was 100%, compared with the neutralization test. Corresponding sensitivity values for the tests were 66.0% (HI), 99.5% (AH), and 99.0% (ELISA). Predictive values for susceptibility were 26.9% (HI), 77.8% (AH), 75.7% (ELISA), 80% (neutralization), and 41.4% as determined by history of infection or vaccination. The predictive value for immunity as determined by history of previous infection or vaccination was 91.8%, compared with 100% for the four serological tests. No false-positive results were seen with any of these tests. Compared with the neutralization test, the HI test had 69 false-negative results, the AH had 1, and the ELISA test had 2. The AH and ELISA tests provided sensitive and specific alternatives to the commonly used HI test for immune status determination.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3897272      PMCID: PMC268379          DOI: 10.1128/jcm.22.2.296-298.1985

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Measles immunization. Successes and failures.

Authors:  A S Yeager; J H Davis; L A Ross; B Harvey
Journal:  JAMA       Date:  1977-01-24       Impact factor: 56.272

2.  Measles and models.

Authors:  K J Bart; W A Orenstein; A R Hinman; R W Amler
Journal:  Int J Epidemiol       Date:  1983-09       Impact factor: 7.196

3.  Problems of spectrum and bias in evaluating the efficacy of diagnostic tests.

Authors:  D F Ransohoff; A R Feinstein
Journal:  N Engl J Med       Date:  1978-10-26       Impact factor: 91.245

Review 4.  Methodologic issues in the evaluation of vaccine effectiveness: measles vaccine at 12 vs. 15 months.

Authors:  J S Marks; G F Hayden; W A Orenstein
Journal:  Am J Epidemiol       Date:  1982-09       Impact factor: 4.897

5.  Re-evaluation of immune status to measles, mumps and rubella viruses in the Canada Health Survey population and the Indochinese refugee population.

Authors:  P W Neumann; J M Weber
Journal:  Can J Public Health       Date:  1984 Jul-Aug

6.  A mathematical model for the hemolysin of measles virus.

Authors:  D R Carrigan; K P Johnson
Journal:  J Virol Methods       Date:  1981-09       Impact factor: 2.014

7.  World eradication of measles.

Authors:  A R Hinman
Journal:  Rev Infect Dis       Date:  1982 Sep-Oct

8.  Measles vaccination. VIII. The occurrence of antibodies against virus envelope components after immunization with inactivated vaccine. Effects of revaccination with live measles vaccine.

Authors:  E Norrby; R Lagercrantz
Journal:  Acta Paediatr Scand       Date:  1976-03

9.  Identification of measles virus-specific hemolysis-inihibiting antibodies separate from hemagglutination-inhibiting antibodies.

Authors:  E Norrby; Y Gollmar
Journal:  Infect Immun       Date:  1975-02       Impact factor: 3.441

10.  Appearance and persistence of antibodies against different virus components after regular measles infections.

Authors:  E Norrby; Y Gollmar
Journal:  Infect Immun       Date:  1972-09       Impact factor: 3.441

View more
  20 in total

1.  Immunosorbent assay based on recombinant hemagglutinin protein produced in a high-efficiency mammalian expression system for surveillance of measles immunity.

Authors:  F Bouche; W Ammerlaan; F Berthet; S Houard; F Schneider; C P Muller
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

2.  The role of secondary vaccine failures in measles outbreaks.

Authors:  R G Mathias; W G Meekison; T A Arcand; M T Schechter
Journal:  Am J Public Health       Date:  1989-04       Impact factor: 9.308

3.  Outbreak of measles among persons with secondary vaccine failure, China, 2018.

Authors:  Zhujiazi Zhang; Meng Chen; Rui Ma; Jingbin Pan; Luodan Suo; Li Lu
Journal:  Hum Vaccin Immunother       Date:  2019-09-05       Impact factor: 3.452

4.  The risk of measles, mumps, and varicella among young adults: a serosurvey of US Navy and Marine Corps recruits.

Authors:  J P Struewing; K C Hyams; J E Tueller; G C Gray
Journal:  Am J Public Health       Date:  1993-12       Impact factor: 9.308

5.  Evaluation of a two-dose measles, mumps, and rubella vaccination schedule in a cohort of college athletes.

Authors:  T R Coté; D Sivertson; J M Horan; M L Lindegren; D M Dwyer
Journal:  Public Health Rep       Date:  1993 Jul-Aug       Impact factor: 2.792

6.  Comparison of the neutralizing and ELISA antibody titres to measles virus in human sera and in gamma globulin preparations.

Authors:  Holger F Rabenau; Branko Marianov; Sabine Wicker; Regina Allwinn
Journal:  Med Microbiol Immunol       Date:  2007-02-17       Impact factor: 3.402

7.  Development of an enzyme-linked immunosorbent assay for immunoglobulin M antibodies against measles virus.

Authors:  F Roodbari; M H Roustai; A Mostafaie; H Soleimanjdahi; R Sarrami Foroshani; F Sabahi
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

8.  Passive hemagglutination test for measles immunity and serodiagnosis.

Authors:  H Sakata; A Sugiura
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

9.  Attenuated Salmonella enterica serovar Typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles virus hemagglutinin, inducing specific immune responses and protection in cotton rats.

Authors:  Marcela F Pasetti; Eileen M Barry; Genevieve Losonsky; Mahender Singh; Sandra M Medina-Moreno; John M Polo; Jeffrey Ulmer; Harriet Robinson; Marcelo B Sztein; Myron M Levine
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

10.  Measles virus-specific cellular immunity in patients with vaccine failure.

Authors:  V H Wu; H McFarland; K Mayo; L Hanger; D E Griffin; S Dhib-Jalbut
Journal:  J Clin Microbiol       Date:  1993-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.